Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Non-Current Assets (2022 - 2026)

HeartSciences (HSCS) has disclosed Non-Current Assets for 4 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 5.48% year-over-year to $2.2 million, compared with a TTM value of $8.3 million through Oct 2025, down 1.35%, and an annual FY2025 reading of $2.1 million, down 4.55% over the prior year.
  • Non-Current Assets was $2.2 million for Q4 2025 at HeartSciences, up from $2.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.2 million in Q4 2025 and bottomed at $130793.0 in Q3 2022.
  • Average Non-Current Assets over 4 years is $1.3 million, with a median of $2.0 million recorded in 2025.
  • Peak annual rise in Non-Current Assets hit 334.83% in 2023, while the deepest fall reached 13.6% in 2023.
  • Year by year, Non-Current Assets stood at $643706.0 in 2022, then decreased by 13.6% to $556147.0 in 2023, then soared by 275.47% to $2.1 million in 2024, then grew by 5.48% to $2.2 million in 2025.
  • Business Quant data shows Non-Current Assets for HSCS at $2.2 million in Q4 2025, $2.0 million in Q3 2025, and $2.1 million in Q2 2025.